• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Temporal Cortical Volume Linked to Depression Relief During Cognitive Behavioral Therapy

by
November 8, 2026
in Health
Reading Time: 2 mins read
0
Temporal Cortical Volume Linked to Depression Relief During Cognitive Behavioral Therapy

Temporal Cortical Volume Linked to Depression Relief During Cognitive Behavioral Therapy

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Pre-treatment cortical gray matter volume within the right middle temporal gyrus is significantly associated with reductions in depressive symptom severity following six months of outpatient cognitive behavioral therapy for unipolar depression, according to a study published in Translational Psychiatry.

Cognitive behavioral therapy represents a first-line treatment for depression, yet clinical responses among patients vary considerably. Investigating neurobiological factors linked to symptom improvement provides an opportunity to better elucidate the structural mechanisms underlying therapeutic change during psychological interventions.

To examine whether baseline cortical gray matter volume relates to symptom reduction, researchers evaluated 52 patients diagnosed with unipolar affective disorders displaying at least mild depressive symptoms on the Beck Depression Inventory-II, alongside 42 healthy control participants. All participants completed clinical assessments and structural magnetic resonance imaging prior to the start of treatment.

Following initial structural imaging and clinical evaluations, the patient group participated in a six-month course of outpatient cognitive behavioral therapy. Researchers reassessed depressive symptom severity at the conclusion of this six-month intervention period to measure change relative to baseline.

Multiple regression analyses tested the associations between pre-treatment cortical gray matter volume and subsequent reductions in depressive symptom severity, applying false discovery rate correction to adjust for multiple testing. To account for potential confounding clinical factors, additional analytical models included measures of anxiety, perceived stress, and childhood trauma as predictors.

Comparing clinical measures across groups revealed that patients exhibited significantly higher depressive symptom severity at baseline and demonstrated greater symptom reduction over time than healthy controls, with differences reaching statistical significance at p < 0.001. However, direct group differences in cortical gray matter volume between patients and healthy controls did not remain statistically significant following false discovery rate correction.

Within the patient cohort, baseline gray matter volume in the right middle temporal gyrus showed a significant positive association with symptom reduction from baseline to follow-up (β = 0.55, pFDR = 0.033). Furthermore, regression modeling demonstrated that right middle temporal gyrus volume accounted for additional variance in symptom reduction beyond established clinical variables, explaining an incremental 15 percent of the variance (ΔR² = 0.15).

The study authors note that these findings link temporal gyrus gray matter volume to symptom improvement following cognitive behavioral therapy in unipolar depression, extending research focus beyond traditionally emphasized limbic regions. Preserved temporal morphology may support the cognitive and emotional processes engaged during psychotherapy, emphasizing the importance of temporal cortical structure in understanding neurobiological correlates of treatment response.

Subject of Research: Neurobiological correlates of cognitive behavioral therapy response in unipolar depression

Article Title: Temporal cortical gray matter volume relates to symptom improvement during cognitive behavioral therapy for depression

Article References: Schöniger, K., Kamrla, R., König, P., Zwiky, E., Küttner, A., Scheiwe, G. S., Andreev, J., Hamann, J. E., Brückner, A., Pletsch, S., Wittig, E., Selle, J., Gussew, A., Deistung, A., Tüscher, O., Wohlgemuth, W. A., & Redlich, R. (2026). Temporal cortical gray matter volume relates to symptom improvement during cognitive behavioral therapy for depression. Translational Psychiatry, 16(1), Article 608. https://doi.org/10.1038/s41398-026-04545-x

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04545-x

Keywords: cognitive behavioral therapy, unipolar depression, gray matter volume, middle temporal gyrus, neuroimaging, structural MRI, psychotherapy response, translational psychiatry, Temporal, cortical, gray, matter

News Source: Glenn Wilkins. (November 8, 2026). Temporal Cortical Volume Linked to Depression Relief During Cognitive Behavioral Therapy. Scienmag.

Tags: cognitive behavioral therapycorticalGraygray matter volumemattermiddle temporal gyrusneuroimagingpsychotherapy responseStructural MRITemporalTranslational Psychiatryunipolar depression
Share12Tweet7Share2ShareShareShare1

Related Posts

Sexual Dysfunction Signals Early Autonomic Involvement in Rare Hereditary Transthyretin Amyloidosis

Sexual Dysfunction Signals Early Autonomic Involvement in Rare Hereditary Transthyretin Amyloidosis

November 17, 2026
Extremely Rare Glycogen Storage Disease Type VI Diagnosed Amidst Celiac Disease

Extremely Rare Glycogen Storage Disease Type VI Diagnosed Amidst Celiac Disease

November 17, 2026

Seventeenth century pirate codes established early collective models for injury compensation

November 17, 2026

Clonal Hematopoiesis Linked to Increased Risk of Intervertebral Disc Degeneration

November 17, 2026

POPULAR NEWS

  • Alloplastic Temporomandibular Joint Replacement Offers Uncertain Benefits After Mandibular Neoplasm Resection

    Alloplastic Temporomandibular Joint Replacement Offers Uncertain Benefits After Mandibular Neoplasm Resection

    29 shares
    Share 12 Tweet 7
  • Serum Mass Spectrometry Predicts Treatment Response in HER2-Positive Breast Cancer

    29 shares
    Share 12 Tweet 7
  • Polypharmacy Linked to Higher Odds of Sarcopenia in Older Adults

    29 shares
    Share 12 Tweet 7
  • Adapted Virtual Presence Tool Proves Feasible in Pilot Manikin Simulation Courses

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sexual Dysfunction Signals Early Autonomic Involvement in Rare Hereditary Transthyretin Amyloidosis

Laboratory Evolution Boosts Trehalose Production in Cupriavidus necator via Osmotic Stress Adaptation

Inherited Mutations in Manganese Transporters Cause Distinct Metabolic Disorders

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.